Why the AnteoTech share price is rocketing 33% today

What did AnteoTech update the ASX with?

| More on:
A man wearing a mask punches the air with joy after getting a negative COVID result on a rapid antigen test.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • AnteoTech shares surge 32.98% to 12.5 cents 
  • The company received regulatory approval for its EuGeni COVID-19 Rapid Antigen Test in Europe 
  • The new registration now covers multiple use claims to include combined nose and throat sampling and nasal mid-turbinate sampling 

The AnteoTech Ltd (ASX: ADO) share price is on the move today.

This comes after the nanotechnology company announced a regulatory update regarding its COVID-19 Rapid Antigen Test (RAT).

At the time of writing, AnteoTech shares are soaring 32.98% higher to 12.5 cents a pop.

AnteoTech expands market access

Investors are fighting to get a hold of the AnteoTech share price after the company received regulatory approval in Europe.

According to its release, AnteoTech advised it has successfully registered an updated EuGeni COVID-19 (RAT) in Europe. This comes under the In Vitro Diagnostic Directive (IVDD) 98/79/EC Regulations.

Management stated that the new registration is for the same core SARS-CoV-2 Ag Rapid Diagnostic Test registered in April 2021. However, this now covers multiple use claims to include combined nose and throat sampling and nasal mid-turbinate sampling.

By securing the latest registration, this strengthens EuGeni COVID-19 RAT’s competitive position by broadening sampling methods to current European trends.

Currently, the European clinical trial that is underway is also evaluating the updated multiple-use claim to be included in the EU Common List registration application.

AnteoTech said it will phase out the original nasopharyngeal test following orders for the updated multiple-use claim test kits.

About the AnteoTech share price

Despite today’s euphoric gains, the AnteoTech share price has lost around 60% in value over the past 12 months.

The company’s shares touched a 52-week low of 8.5 cents last week after being pounded by the broader market weakness.

Based on valuation metrics, AnteoTech presides a market capitalisation of roughly $374.3 million.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A doctor appears shocked as he looks through binoculars on a blue background.
Healthcare Shares

What’s the outlook for the CSL share price in July?

We take a look at what the experts are saying about the biotech company's shares.

Read more »

Photo of a group of scientists cheering while working in a lab as the Race Oncology share price skyrockets today on positive study results
Healthcare Shares

Why is the Race Oncology share price soaring 13% today?

New trial results have excited ASX investors.

Read more »

Rising arrow on a blue graph symbolising a rising share price.
Healthcare Shares

Starphama share price lunges 5% on product relaunch

Early support for Starphama on Thursday has it off to a great start.

Read more »

Man with rocket wings which have flames coming out of them.
Healthcare Shares

Why is the Paradigm share price rocketing 20% higher today?

The Paradigm share price is having a very strong day...

Read more »

A businessman presents a company annual report in front of a group seated at a table
Healthcare Shares

Own Immutep shares? Here are 3 takeaways from the company’s investor update

Investors were mute to the update.

Read more »

A health professional wearing a stethoscope and scrubs shrugs with uncertainty.
Healthcare Shares

Has CSL been growing its dividend?

Is the biotech giant still increasing its dividends in a post-COVID world?

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Healthcare Shares

Why is the 4DMedical share price exploding 40% today?

4DMedical signed a three-year, nationwide contract with I-MED Radiology Network.

Read more »

Two medical researchers in white coats collaborate over a computer screen of data in a medical research laboratory
Healthcare Shares

What was the Sonic Healthcare share price when it first listed on the ASX?

Sonic Healthcare has an interesting history...

Read more »